Latest News - The Aurum Institute

Understanding the impact of women's correct risk perception on human immunodeficiency virus diagnosis: Insights from South Africa.

Wand, H., Moodley, J., Reddy, T. and Naidoo, S., 2024. Understanding the impact of women’s correct risk perception on human immunodeficiency virus diagnosis: Insights from South Africa. Internation...
Exposure to common infections may shape basal immunity and potentially HIV-1 acquisition amongst a high-risk population in Coastal Kenya.

Fwambah, L., Andisi, C., Streatfield, C., Bromell, R., Hare, J., Esbjörnsson, J., Ndung’u, T., Sanders, E.J., Hassan, A.S. and Nduati, E., 2024. Exposure to common infections may shape basal immuni...
Preventing Stunting in South African Children Under 5: Evaluating the Combined Impacts of Maternal Characteristics and Low Socioeconomic Conditions.

Wand, H., Naidoo, S., Govender, V., Reddy, T. and Moodley, J., 2024. Preventing Stunting in South African Children Under 5: Evaluating the Combined Impacts of Maternal Characteristics and Low Socioeco...
Effect of digital adherence technologies on treatment outcomes in people with drug-susceptible tuberculosis:

In people with drug-susceptible tuberculosis: four pragmatic, cluster-randomised trials. Jerene, D., van Kalmthout, K., Levy, J., Alacapa, J., Deyanova, N., Dube, T., Mganga, A., Tasca, B., Bogdanov,...
The Aurum Institute Welcomes Prof. Vinodh Edward as Group Chief Operating Officer

The Aurum Institute Board is thrilled to announce Prof. Vinodh Edward's appointment as the new Group Chief Operating Officer (GCOO), effective 1 January 2025. This strategic move marks a significant m...
Process Evaluation of Pragmatic Cluster-Randomized Trials of Digital Adherence Technologies for Tuberculosis Treatment Support: A Mixed-Method Study in Five Countries

Madden, N., Tadesse, A.W., Leung, C.L., Gonçalves Tasca, B., Alacapa, J., Deyanova, N., Ndlovu, N., Mokone, N., Onjare, B., Mganga, A. and van Kalmthout, K., 2025. Process Evaluation of Pragmatic Clu...
Inflammatory profiles in sputum and blood of people with TB with and without HIV coinfection.

Auld, S.C., Queiroz, A.T., Araujo-Pereira, M., Maenetje, P., Mofokeng, N., Mngomezulu, L., Masilela, D., Dobosh, B., Tirouvanziam, R., Kornfeld, H. and Andrade, B.B., 2024. Inflammatory profiles in sp...
Preferences for HIV pre‐exposure prophylaxis formulations and delivery among young African women: results of a discrete choice experiment

Dlamini, W.W., Mirembe, B.G., Krows, M.L., Peacock, S., Kotze, P.L., Selepe, P., Smit, J., Mandona, N., Louw, C., Nuwagaba‐Biribonwoha, H. and Omollo, V.O., 2025. Preferences for HIV pre‐exposure...
Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043–02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial

Heinrich, N., de Jager, V., Dreisbach, J., Gross-Demel, P., Schultz, S., Gerbach, S., Kloss, F., Dawson, R., Narunsky, K., Matt, L. and Wildner, L., 2025. Safety, bactericidal activity, and pharmacok...
Review of Impact of Risk Reduction Sessions on Sexual Behaviors in HIV Prevention Trials: Insights from Africa

Wand, H., Reddy, T., Moodley, J., Naidoo, S. and Ramjee, G., 2025. Review of Impact of Risk Reduction Sessions on Sexual Behaviors in HIV Prevention Trials: Insights from Africa. Archives of Sexual Be...
“Time to Change”: To What Extent Could Non-Sputum Sampling Accelerate the Fight Against Tuberculosis—A Qualitative Study Among End-Users

Fargnoli, V., Hanh, H.T.M., Hoang, L.N., Mahesh, A., Mqedlana-Ntombela, N., Xavier, J., Kohli, M., Velen, K. and Shilton, S., 2025. “Time to Change”: To What Extent Could Non-Sputum Sampling Acce...
Risk factors for PrEP and ART medication adherence challenges in cis-gender South African men who have sex with men in Johannesburg and Pretoria

Pienaar, J., Tsope, L., Mabena, M., Komane, P., Sibanyoni, M., Ramashala, B., Wahome, E., Denousse, C., Gakunu, A., van der Elst, E.M. and Giovenco, D., 2025. Risk factors for PrEP and ART medication ...
Aurum Showcases Innovation at Global Summit on AI

Aurum joined leading voices at the Global Summit on AI in Africa 2025 and the Gates Foundation AI Grand Challenges Community convening in Kigali, Rwanda—bringing African expertise and innovation to ...
North West Health intensifies fight against TB

...
Request for Proposals: Supply of Itraconazole Tablets/Capsules for Histoplasmosis Treatment

The Aurum Institute, in partnership with Market Access Africa and with funding from Unitaid, invites qualified and capable suppliers and manufacturers to submit proposals for the procurement and/or re...
Youth Day 2025: Five Years of Action, Led by the Youth for the Youth

In the uncertain months of 2020, as the world came to a standstill and health systems were tested beyond limits, a quiet revolution began led not by institutions, but by the youth. It started with a q...

Understanding the impact of women's correct risk perception on human immunodeficiency virus diagnosis: Insights from South Africa.

Exposure to common infections may shape basal immunity and potentially HIV-1 acquisition amongst a high-risk population in Coastal Kenya.

Preventing Stunting in South African Children Under 5: Evaluating the Combined Impacts of Maternal Characteristics and Low Socioeconomic Conditions.

Effect of digital adherence technologies on treatment outcomes in people with drug-susceptible tuberculosis:

The Aurum Institute Welcomes Prof. Vinodh Edward as Group Chief Operating Officer

Process Evaluation of Pragmatic Cluster-Randomized Trials of Digital Adherence Technologies for Tuberculosis Treatment Support: A Mixed-Method Study in Five Countries

Inflammatory profiles in sputum and blood of people with TB with and without HIV coinfection.

Preferences for HIV pre‐exposure prophylaxis formulations and delivery among young African women: results of a discrete choice experiment

Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043–02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial

Review of Impact of Risk Reduction Sessions on Sexual Behaviors in HIV Prevention Trials: Insights from Africa

“Time to Change”: To What Extent Could Non-Sputum Sampling Accelerate the Fight Against Tuberculosis—A Qualitative Study Among End-Users

Risk factors for PrEP and ART medication adherence challenges in cis-gender South African men who have sex with men in Johannesburg and Pretoria

Aurum Showcases Innovation at Global Summit on AI

North West Health intensifies fight against TB

Request for Proposals: Supply of Itraconazole Tablets/Capsules for Histoplasmosis Treatment

Youth Day 2025: Five Years of Action, Led by the Youth for the Youth

Popular Tags

Most Read

Recent Posts